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Regulation of expression of the intestinal epithelial actin-binding protein, villin, is poorly
understood. The aim of this study was to determine whether Wnt5a stimulates Ror2 in
intestinal epithelia caused transient increases in phospho-ERK1/2 (pERK1/2) and subse-
quently increased expression of villin transcript and protein. To demonstrate Wnt5a–Ror2
regulation of villin expression, we overexpressed wild-type, truncated, or mutant Ror2 con-
structs in HT29 adenocarcinoma cells and non-transformed fetally derived human intestinal
epithelial cells, added conditioned media containing Wnt5a and measured changes in
ERK1/2 phosphorylation, villin amplicons, and protein expression by RT-PCR andWestern
blot techniques.Wnt5a addition caused a transient increase in pERK1/2, which was maxi-
mal at 10min but extinguished by 30min.Transient transfectionwith a siRNA duplex against
Ror2 diminished Ror2 amplicons and protein and reduced the extent of pERK1/2 activa-
tion. Structure–function analysis revealed that the deletion of the cysteine-rich, kringle, or
tyrosine kinase domain or substitution mutations of tyrosine residues in the intracellular
Ser/Thr-1 region of Ror2 prevented theWnt5a stimulation of pERK1/2. Deletion of the intra-
cellular proline and serine/threonine-rich regions of Ror2 had no effect onWnt5a stimulation
of pERK1/2. The increase in villin expression was blocked by pharmacological inhibition of
MEK-1 and casein kinase 1, but not by PKC and p38 inhibitors. Neither Wnt3a nor epi-
dermal growth factor addition caused increases in villin protein. Our ﬁndings suggest that
Wnt5a/Ror2 signaling can regulate villin expression in the intestine.
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INTRODUCTION
The molecular determinants of villin production in the intestine
are largely unknown.Villin is a 92.5-kDa, actin-binding cytoskele-
tal protein which associates with the apex and axial bundle struc-
tures of intestinalmicrovilli tomediate cytoskeletal organization in
the intestine (Coluccio and Bretscher, 1989; George et al., 2007).
Studies have shown that the knock down of endogenous villin
expression in intestinal epithelial cells induced low rates of brush
border assembly (Costa de Beauregard et al., 1995; Pinson et al.,
1998). Consequently, elucidating mechanisms which regulate
villin expression in vitro could enhance understanding of deter-
minants which mediate normal epithelial development in the gut.
In the adult small intestine, villin protein expression is
detected along the entire crypt–villus axis, with levels of villin
protein expression enhanced toward the villus tip (Maunoury
et al., 1992). Ror2, a tyrosine kinase receptor, is the recep-
tor for Wnt5a. Ror2 is expressed in murine small intesti-
nal epithelia along the entire crypt–villus axis (Pacheco and
MacLeod, 2008). Activation of the extracellular calcium sens-
ing receptor (CaSR) increased Wnt5a secretion from colonic
myoﬁbroblasts. CaSR activation increased Ror2 expression on
the epithelia. This paracrine Wnt5a/Ror2 signaling in intestinal
epithelial cells led to the activation of the caudal type homeobox
transcription factor 2 (CDX2), and sucrase-isomaltase (Pacheco
and MacLeod, 2008) suggestive of increased epithelial differenti-
ation. Wnt5a/Ror2 stimulates non-canonical Wnt signaling while
Wnt3a activates the canonical Wnt/β-catenin dependent path-
way (Mikels and Nusse, 2006). Villin is regarded a marker for
differentiated epithelial cells because of its distinctive expres-
sion gradient along the villus–crypt axis (Khurana and George,
2008). It is not known if Wnt5a/Ror2 signaling inﬂuences villin
expression.
In H. pylori infected gastric cells, the villin promoter has been
shown to be increased by Elk-1, a downstream nuclear tran-
scription factor which is activated by ERK1/2 phosphorylation
(Rieder et al., 2005). This suggested to us that the activation
of ERK1/2 might, in the appropriate conditions, inﬂuence villin
expression in intestinal epithelia. As described herein,we observed
that Wnt5a added to non-transformed fetally derived intestinal
cells orHT29 adenocarcinoma cells,whenRor2was overexpressed,
increased villin transcript and protein expression. We show that
this effect required the cysteine-rich, kringle, and tyrosine kinase
domain(s) of Ror2. TheWnt5a stimulation of pERK1/2 and villin
expression occurred using Ror2 constructs lacking the proline
and serine/threonine-rich regions of the intracellular tail (BDB
Ror2). Mutations of tyrosine residues in the serine/threonine-1
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rich region of Ror2 (5YF Ror2) prevented Wnt5a stimulation of
transient ERK1/2 phosphorylation and subsequent villin expres-
sion. This is the ﬁrst demonstration that Wnt5a activating the
BDB Ror2 signals differently than whenWnt5a interacts with 5YF
Ror2. Addition of Wnt3a or epidermal growth factor (EGF) did
not result in villin expression in the presence of wild-type Ror2
overexpression. Together, our results deﬁne a causal relationship
of Wnt5a/Ror2 signaling in intestinal epithelial cells to transiently
increase pERK1/2 and lead to villin protein expression.
MATERIALS AND METHODS
MATERIALS
Inhibitors such as PD098059 (MEK-1 inhibitor), SB 203580 (a p38
MAPK inhibitor), Bisindolylmaleimide I (inhibitor of PKC iso-
types: -α, -β, -γ, -δ, -ε), andD4476 (a casein kinase I inhibitor)were
purchased from EMDCalbiochem-Novabiochem (SanDiego,CA,
USA). Other investigations have demonstrated that at the follow-
ing concentrations: 10μM PD 098059 (Alessi et al., 1995; Aliaga
et al., 1999), 10μMSB 203580 (Clerk et al., 1998; Zhou et al., 2005;
Tu and Perdue, 2006), 1μM Bisindolylmaleimide I (Toullec et al.,
1991;Vayro and Silverman, 1999), and 100μMD4476 (Rena et al.,
2004; Bryja et al., 2007), ERK MAPK, p38 MAPK, PKC and CK1
and inhibited, respectively, in a variety of cell lines.
CELL CULTURE
The human colorectal adenocarcinoma HT29 cell line and mouse
L-cells were purchased from American Tissue and Cell Cul-
ture (Rockville, MD, USA). Fetally derived, non-transformed,
human intestinal epithelial cells (HIEC) were obtained from Dr.
Boudreau (University de Sherbrooke, Sherbrooke, QC, Canada).
The HT29 and L-cells were grown in Dulbecco’s modiﬁed eagle
media (DMEM) supplemented with 10% fetal bovine serum
(FBS), and 0.05% Penstrep (all purchased from Invitrogen, Carls-
bad, CA, USA). The non-transformed fetal HIECs were cul-
tured in OPTI-MEM supplemented with 4% FBS (Invitrogen),
0.05% l-glutamine (Invitrogen), 0.02% EGF (Sigma, Oakville
ON, Canada), and 0.05% HEPES (BioShop, Burlington, ON,
Canada).
All cells were maintained at 37˚C, in 95% air, 5% CO2 atmos-
pheric conditions. HT29 cells and HIECs were passaged every
4–5 days, with 0.25 and 0.05% Trypsin (Invitrogen, Carlsbad,
CA, USA), respectively. Only HT29 cells passaged within the ﬁrst
6 weeks of initial thawing and passage 16–22 HIECs were used.
Early passage cells were used to prevent spontaneous differen-
tiation and transformation that is often observed in late-passage
carcinoma-derived intestinal epithelial cell lines (Pinto et al., 1983;
Vachon and Beaulieu, 1992).
PREPARATION OF Wnt5a CONDITIONED MEDIA
Mouse L-cells, stably transfected withWnt5a plasmid,were seeded
on 10 cm plates and supplemented with 10% DMEM, as previ-
ously described. After 24 h, cells were then incubated in 0.5mM
Ca2+ DMEM containing 0.1% l-glutamine and 0.05% Penstrep
and supplemented with 0.2% bovine serum albumin. This media
was collected 48 and 96 h afterward. Upon collection, media was
centrifuged at 1000 RPM for 5min and the remaining supernatant
was isolated, divided into aliquots, and kept at−30˚C for later use.
TRANSIENT TRANSFECTIONS
All DNA plasmid transfections completed for subsequent West-
ern blot analysis and RT-PCR were performed using the Superfect
transfection reagent, according to the manufacturer’s instructions
(Qiagen, Mississauga, ON, Canada). The wild-type Ror2 plas-
mid (WT Ror2) and Ror2 constructs containing deletions of:
the cysteine-rich domain, aa 170–300 (ΔCRD Ror2); the kringle
domain, aa 316–395 (ΔK Ror2); regions including and distal to
the tyrosine kinase domain, aa 502–944 (ΔRS Ror2); regions
including and distal to the tail of tyrosine kinase domain, aa
749–944 (BDB Ror2), and a Ror2 construct containing substi-
tutions of phenylalanine for ﬁve tyrosine residues in the ﬁrst
serine/threonine-rich domain, tyrosines 818, 824, 830, 833, 838
(5YF Ror2) were generous gifts from Y. Minami (Kobe Uni-
versity, Kobe, Japan). The described constructs are summarized
in Figure 1A. Expression levels of WT Ror2, ΔK Ror2, ΔRS
Ror2, BDB Ror2, and 5YF Ror2 in HT29 cells are shown in
Figure 1B. The expression of RS and BDB were higher then the
wild-type Ror2 (1.8× and 2.8×, respectively) while expression of
the ΔK Ror2 and 5YF Ror2 were consistently lower (0.30× and
0.26×, respectively) then wild-type Ror2. The short-interfering
RNA duplex pool against Ror2 (siRNARor2) was comprised of
four target sequences: 5′-GUCAUCGCUUGCCUGUUC-3′, 5′-
ACCAACCCUUGAGCAUGA-3′, 5′-GCAAUGUGCUGGUGUAC
GA-3′, 5′-GAACCGGACUAUUUAUGUG-3′and was purchased
from Dharmacon (Hornby, ON, Canada).
WESTERN BLOT ANALYSIS
HT29 cells andHIECswere seededon6-well plates; 24 h later, these
cells were transfected with 2.0μg of a Ror2 plasmid construct
(as previously described) or with 200 nM of siRNARor2 (previ-
ously described) using Superfect (Qiagen), according to manu-
facturer’s instructions. The plates were serum starved in 0.5mM
Ca2+ DMEM supplemented with 0.2% BSA, 0.1% l-glutamine
and 0.05% Penstrep, as described previously. After 18 h of serum
starvation, the cells were incubatedwithWnt5a conditionedmedia
for 0, 2, 5, 10, 30, 60min. Following incubation, cells were rinsed
once with ice-cold PBS containing 1mM sodium orthovana-
date and 25mM sodium ﬂuoride. Cells were subsequently lysed
in 20mM Tris–HCl, ph 7.4, 150mM NaCl, 1mM EDTA, 1mM
EGTA, 25mM NaF, 1% Triton X-100, 10% glycerol, 1mM dithio-
threitol, 1mM sodium orthovanadate, and a cocktail of protease
inhibitors containing 10μM each of pepstatin, soybean trypsin
inhibitor, leupeptin, aprotinin, calmodulin.
Lysates (40–60μg total protein) were loaded onto an
8% (for villin immunoblotting), 10% (for pERK1/2 or
ERK1/2 immunoblotting), or 12% (for Ror2 or FLAG-tag, N-
DYKDDDDK-C, immunoblotting) Bisacrylamide gel. Proteins
were transferred electrophoretically onto a polyvinylidene diﬂuo-
ride (PDVF) membrane (Millipore, Bedford, MA, USA). Follow-
ing transfer, membranes were blocked for 1 h in 5% milk in 1×
Tris Buffered Saline and 0.1% Tween-20 (1×TBS-T). To detect
expression of phosphorylated-ERK1/2 (pERK1/2), total amounts
of ERK1/2 (ERK1/2), Ror2, FLAG-tag, and villin protein, mem-
branes were incubated with a polyclonal rabbit antibody speciﬁc
for pERK1/2, ERK1/2, Ror2, FLAG-tag, or villin in 1XTBS-T with
5% BSA in a 1:1000 dilution (antibodies purchased from Cell
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FIGURE 1 | (A) Schematic representation of the Ror2 constructs used in
these experiments. Full length Ror2 is characterized by three extracellular
domains (Ig-like, cysteine-rich and kringle domains), as well as four
conserved intracellular domains (tyrosine kinase, serine/threonine-rich-1,
proline-rich, serine/threonine-rich-2 domains). The various Ror2 constructs
are characterized by deletions of speciﬁc putative domains of Ror2. The
ΔCRD Ror2 contains a deletion of the cysteine-rich domain. In the ΔK Ror2
construct, the kringle domain has been truncated. In RS Ror2, a majority of
the tyrosine kinase domain, as well as regions distal to this domain have
been deleted. The 5YF Ror2 construct contains ﬁve substitution mutations
in the Ser/Thr-1 region, where ﬁve tyrosine residues have been replaced by
phenylalanines.The BDB Ror2 construct contains a deletion of the Ser/Thr-1,
proline, and Ser/Thr-2 rich regions. (B) Expression levels ofWT Ror2, ΔK,
RS, BDB, and 5YF in HT29 cells with beta-actin as a loading control.
Signaling Technology Inc., Danvers, MA, USA). Membranes were
left at 4˚C, shaking overnight. To detect β-actin protein expression,
membranes were incubated with a mouse antibody speciﬁc for
β-actin (Sigma, St Louis, MO, USA) diluted to 1:10000 in 1XTBS-
T, under similar conditions and incubated with an anti-rabbit
or anti-mouse secondary conjugated to horseradish peroxidase
(Sigma, St Louis, MO, USA) in 1XTBS-T containing 5% milk
for 1 h. Protein bands were visualized by incubating the mem-
brane with luminol and peroxide substrates from a commercially
purchased chemiluminescence kit (SuperSignal, Pierce Chemical;
Rockford, IL, USA).
REVERSE TRANSCRIPTASE-POLYMERASE CHAIN REACTION
A two-step RT-PCR for villin was performed to assess for
differential gene expression. RNA was extracted from Wnt5a-
challenged,Ror2-overexpressingHT29 cells and non-transformed
fetal HIECs. RNA was isolated using TRIzol, according to manu-
facturer’s instructions (Invitrogen).
cDNA synthesis was performed from total RNA using the
Omniscript reverse transcriptionkit as permanufacturer’s instruc-
tions (Qiagen; Mississauga, ON, Canada). Total 1.0μg of cDNA,
from the resulting cDNA synthesis, was combined with the appro-
priate primers for human villin along with a reverse-transcriptase
enzyme, Taq Polymerase (from a purchased Reverse-Transcriptase
kit by Qiagen; Mississauga, ON, Canada). Primers for villin are
sense 5′-TAG CTG TGG TTG TAA AGC AGT ACC-3′ and anti-
sense 5′-GGT ATCATC TTT CTGAAG GAA TAG G-3′. The PCR
cycle parameters were as follows: an initial 60 s initial denatu-
ration period at 104˚C; 30 ampliﬁcation cycles consisting of a
30-s-denaturation period at 104˚C; a 30-s-annealing period at
55˚C, and a 1-min elongation period at 72˚C; a ﬁnal 10-min elon-
gation period at 72˚C. The resulting PCR product was loaded
onto a 1% agarose gel and visualized by UV light. The sequence
of the RT-PCR product from the described experiment was: 5′-
CGATATTAGTCCTACACCAATTGAAGTGAAATTTTGCAGATG
TGCCTATGAGCACAAACTTCTGTGGCAAATGCCAGTTTTGT
TTAATAATGTACCTATTCCTCAGAAAGATGATA-3′.
DENSITOMETRY
Densitometry was performed onX-rays of developedWestern blot
experiments. The densities of individual bands were measured
using ImageJ (version 1.40g). Measured experimental densities
were normalized against the density of the appropriate loading
control. These corrected densities were normalized to the most
intense band in the given experiment.
STATISTICS
Data are presented as means± SE of at least three separate
experiments. Student’s t -tests were performed on data, where
appropriate. Statistical signiﬁcance was deﬁned as: P < 0.05.
RESULTS
Wnt5a INTERACTION WITH Ror2 STIMULATED ERK1/2
PHOSPHORYLATION IN ADENOCARCINOMA-DERIVED HT29 CELLS
We ﬁrst determined whether Wnt5a and Ror2 would stimulate
the ERK1/2 (p44/42) MAPK cascade in adenocarcinoma-derived
HT29 intestinal epithelial cells (Figure 2). ERK1/2 activation is
characterized by dual phosphorylation of both the ERK1 and
ERK2 (p44 and p42) isotypes. Approximately 24 h after seeding on
6-well plates, cells were transfected with 2.0μg of (full length)WT
Ror2DNAplasmid, and subsequently challengedwithWnt5a con-
ditioned media (Wnt5a CM) for 0, 2, 5, 10, 30, 60min (along with
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FIGURE 2 |Wnt5a stimulation of Ror2 induced ERK 1/2 (p44 and p42)
phosphorylation in HT29 cells. (A) HT29 cells were grown in DMEM
supplemented with 10% FBS, transfected withWT Ror2 or no plasmid. Cells
were serum starved for 18 h. Cells were challenged withWnt5a CM for 0, 2,
5, 10, 30, 60min.Western blot analysis screening for total (phosphorylated
and unphosphorylated) ERK1/2 expression was included as loading control.
(B) HT29 cells were transiently transfected with either 0, 50, 100, 200, and
300 nM siRNARor2 and blotted for Ror2. (C,D) HT9 cells were transfected with
either siRNARor2 or no plasmid in the presence (D) or absence ofWnt5a CM
for the time points listed above.Western immunoblotting for total ERK1/2
was included as an internal loading control. Blots shown are representative of
three separate experiments with similar results.
a negative control lacking plasmid). It was determined that lev-
els of both p44 and p42 phosphorylation transiently and robustly
increased between 2 and 30min of Wnt5a CM treatment. Max-
imal ERK1 and 2 phosphorylation occurred at 5–10min, before
diminishing to baseline levels at 60min (Figure 2A, bottompanel).
In contrast, in mock-transfected HT29 cells, which were Wnt5a-
challenged in a similar manner, levels of ERK1/2 phosphorylation
were substantially attenuated; dual-ERK1/2 phosphorylation was
observed only at 10min (Figure 2A, middle panel).
To verify whether the Ror2 receptor is a necessary mediator
of Wnt5a-induced ERK1/2 activation, we completed experiments
employing the use of a short-interfering RNA duplex aimed
speciﬁcally against the Ror2 (siRNARor2). We have shown that in
response to increasing transfection concentrations of siRNARor2 in
HT29 cells,Ror2 receptor expressionwas dose-dependently down-
regulated (Figure 2B). At 200 nM concentrations of siRNARor2,
immunoreactive Ror2 expression was barely detectable in cell
lysates; we used this concentration of siRNARor2 for subsequent
experiments.
Because ERK1/2 is an extracellular signal-regulatedMAPK, and
may be activated by a diverse set of agonists including cytokines,
growth factors, and serum elements, we elected to determine
whether the serum elements in the medium alone were sufﬁ-
cient to induce robust increases in ERK1/2 phosphorylation in
these cells. ThroughWestern blot analysis screening for phospho-
rylated ERK1 and 2 (pERK1/2), low levels of pERK2were observed
in cells where Ror2 receptor expression had been silenced and
subsequently treated with minimum serum (0.2% BSA) media,
which does not contain Wnt5a (Figure 2C, bottom panel), or
where cells had been mock-transfected, and treated in a similar
manner (Figure 2C; top panel).
Wewent on to compare ERK1/2 phosphorylation inHT29 cells,
whichhadbeen transfectedwithWTRor2or siRNARor2 and subse-
quently treatedwithWnt5aCM.Aspreviously shown,weobserved
that in WT Ror2-transfected cells, Wnt5a challenge induced a
transient increase in dual-ERK1/2 phosphorylation (Figure 2A,
bottom panel). However, upon similar challenge with Wnt5a CM
in siRor2-transfected cells, ERK1/2 phosphorylation was attenu-
ated (Figure 2D). The ERK1/2 phosphorylation was restricted to
the ERK2 (p42) isotype.
From these experiments, we conclude that activation of both
ERK1/2 (p44/p42)occurred transiently in response toWnt5a addi-
tion to Ror2-overexpressing epithelial cells. Furthermore, these
ﬁndings suggest that medium change or knocking down expres-
sion of Ror2 have a comparable effect – stimulating p42 activation
exclusively. We therefore elected to use the transient activation of
both p44 and p42 as the index of ERK1/2 phosphorylation.
Wnt5a-ACTIVATION OF ERK1/2 INDUCED VILLIN PROTEIN EXPRESSION
IN ADENOCARCINOMA CELLS
Earlier studies using gastric cancer cells have reported that activa-
tionof theERK1/2MAPKcascade can induceElk-1mediated villin
promoter activity (Rieder et al., 2005). Because Elk-1 is activated
by phosphorylated ERK1/2, we went on to determine whether
Wnt5a–Ror2 induced ERK1/2 activation would enhance villin
expression in HT29 cells.We assessed villin expression by RT-PCR
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andWestern analysis, onHT29 cells overexpressing Ror2 and chal-
lenged with Wnt5a CM for 18 or 24 h, respectively. Using the
BLAST algorithm, this sequence was shown to be 100% homolo-
gouswith human villinmRNA. In cells thatweremock-transfected
and/or left untreated, basal levels of villin transcript expression
were low. In contrast, when WT Ror2-overexpressing cells were
challenged with Wnt5a CM for 24 h, levels of villin amplicon
were substantially upregulated. This upregulated villin transcript
expression was lost in the presence of PD 098059 (10μM), a spe-
ciﬁc MEK-1 inhibitor, which is directly upstream of the ERK1/2
MAPK cascade (Figure 3A).
There was a noticeable increase in villin protein produc-
tion in WT Ror2-overexpressing cells challenged with Wnt5a
CM for 24 h. In contrast, villin protein expression was low in
mock-transfected and/or untreated cells (Figure 3B). Again, this
increased villin protein expression was lost in similarly treatedWT
Ror2-overexpressing cells, in the presence of PD 098059 (10μM;
Figure 3B).
To assess whether other intracellular effectors could be involved
in Wnt5a-stimulated villin protein production, we screened for
immunoreactive villin in cells treated with inhibitors of PKC
and p38 MAPK. Again, we observed low levels of villin pro-
tein in untreated or mock-transfected HT29 cells. Upon Wnt5a
CM challenge in WT Ror2-overexpressing cells, villin protein
production was noticeably increased. In the presence of Bisin-
dolylmaleimide I (1μM; an inhibitor of PKC-α, -β, -γ, -δ, -ε),
and SB203580 (10μM; a speciﬁc inhibitor of all p38 isotypes),
levels of villin protein production remained increased in Wnt5a
CM-challenged Ror2-overexpressing cells. Addition of D4476
(100μM;aCKI inhibitor) preventedWnt5a-induced villin expres-
sion in WT Ror2-expressing cells (Figure 3C). Taken together,
these results suggest that Wnt5a–Ror2 induced ERK1/2 activa-
tion, which enhanced villin protein production in HT29 cells.
This Wnt5a-induced ERK1/2 phosphorylation also required CKI
involvement. However, PKC and p38 MAPK did not appear to
mediate this effect.
Wnt5a-INDUCED ERK1/2 ACTIVATION AND SUBSEQUENT VILLIN
PROTEIN PRODUCTION REQUIRED SPECIFIC FUNCTIONAL REGIONS OF
Ror2
Having established Ror2 functionality in mediating Wnt5a’s
induction of ERK1/2, we went on to elucidate the speciﬁc regions
of the receptor necessary in mediating this affect. To verify which
domains of Ror2 are necessary for induction of ERK1/2 phospho-
rylation, we completed further Wnt5a time course experiments,
assessing ERK1/2 phosphorylation via Western blot analysis, in
HT29 cells overexpressing truncated or mutated Ror2 constructs.
A set of control cells, which overexpress WT Ror2, were run
concurrently with each experiment. Both experimental and con-
trol cells were treated with Wnt5a CM for 0, 2, 5, 10, 30, and
60min. Experimental and control lysates were run concurrently
on acrylamide gels and transferred onto PDVFmembranes within
the same apparatus and exposed on the same piece of ﬁlm to
ensure consistency. In cells expressing a Ror2 receptor where
the cysteine-rich domain has been truncated (ΔCRD Ror2), or
the kringle domain has been deleted (ΔK Ror2), or a major-
ity of the tyrosine kinase domain and regions distal to this
domain have been deleted (RS Ror2), or where ﬁve tyrosine
residues of the serine/threonine-1 domain had been substituted
with phenylalanines (5YF Ror2), levels of Wnt5a-induced ERK1/2
phosphorylation were substantially attenuated compared to WT
Ror2-transfected cells (Figures 4A–D).
In contrast, in cells expressing a BDB Ror2 receptor, where only
the distal proline and serine/threonine-rich regions of the receptor
had been deleted, levels of both ERK1/2 (p44 and p42) robustly
increased over the course of an hour. The pattern of Wnt5a-
induced ERK1/2 phosphorylation in these BDB Ror2-expressing
cells was similar to that of control WT Ror2-transfected cells
(Figure 4E).
Densitometry conﬁrmed that the intensity of ERK1/2 phos-
phorylation in WT Ror2-transfected control cells incubated with
Wnt5a CM for 10min was signiﬁcantly increased compared to
baseline. Additionally, the degree of ERK1/2 phosphorylation was
signiﬁcantly greater in Wnt5a-challenged WT Ror2 HT29 cells
compared to similarly treated cells expressing ΔCRD, ΔK, RS,
or 5YF Ror2 (Figures 4A–D). Densitometry on three separate
ERK1/2 time course experiments conﬁrmed that the degree and
pattern of ERK1/2 activation in Wnt5a-treated BDB Ror2-cells
resembled that of similarly treated control cells (Figure 4E, right
panel). Expression levels of WT,ΔK, RS, BDB, and 5YF Ror2 con-
structs is shown in Figure 1B. We note that overexpression of
RS and BDB relative to WT Ror2 generated opposite effects on
ERK1/2 phosphorylation, while reduced expression of ΔK and
5YF relative toWT Ror2 generated comparable effects on ERK1/2
phosphorylation.
We then assessed levels of villin protein production in HT29
cells transfected with a Ror2 receptor where the cysteine-rich
domain has been deleted (ΔCRD Ror2), ﬁve tyrosine residues on
the Ser/Thr-1 domain had been substitution-mutated (5YF Ror2),
or where the proline/serine rich regions of the receptor had been
deleted (BDBRor2). Immunoblotting for villin demonstrated that
in mock-transfected or unchallenged WT Ror2-expressing cells,
levels of villin protein production were low. However, in WT
Ror2-overexpressing cells challenged with Wnt5a CM for 24 h,
levels of villin protein production were increased. In contrast, in
ΔCRD Ror2 and 5YF Ror2-overexpressing cells, treatment with
Wnt5aCMdid not enhance villin protein production (Figure 5A).
However, in cells where the proline and serine/threonine-rich
domains of the Ror2 receptor had been deleted (BDB Ror2), upon
Wnt5a challenge, levels of villin protein productionwere increased
(Figure 5B).
Consistent with previous ﬁndings, our work suggested that
the extracellular cysteine-rich domain is a necessary compo-
nent of Wnt5a-induced ERK1/2 activation and subsequent villin
protein production. Additionally, these experiments also show
that despite the fact that both 5YF and BDB Ror2 rendered
the Ser/Thr-1 domain of the receptor inactive, either by muta-
tion or deletion, respectively, these Ror2 constructs signaled in
a different manner. It appears that the expression of the tyro-
sine residues in the Ser/Thr-1 was necessary for Wnt5a’s interac-
tion with full length Ror2 to stimulate ERK1/2. However, dele-
tion of regions including and distal to Ser/Thr-1 did not affect
Wnt5a stimulation of ERK1/2 and subsequent increases in villin
protein.
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FIGURE 3 |Wnt5a interaction with Ror2 upregulated villin transcript
and increased protein expression via an ERK1/2-dependent
mechanism. (A) HT29 cells were transfected with Ror2 (no plasmid as
control) and treated withWnt5a and/or PD 098059 (1μM), DMSO (as
shown in legend). RT-PCR analysis for Villin (GAPDH as control) was
performed. (B) Villin protein expression was upregulated inWT
Ror2-transfected cells treated withWnt5a conditioned media for 24 h,
compared to mock-transfected and/or untreated cells. In the presence of
a speciﬁc MEK-1 inhibitor (PD 098059; 1μM), the increased villin protein
expression was lost. Western blotting for β-actin was performed as an
internal loading control. (C) Inhibitors of PKC (Bisindolylmaleimide I; 1μM)
and p38 (SB 203580; 1μM) did not, but a CKI inhibitor (D4476; 100μM)
did preventWnt5a-induced villin protein increases. Immunoreactive villin,
at levels similar to that ofWnt5a-treatedWT Ror2-transfected HT29
control cells, were detected in cells treated in a similar manner in the
presence of a Bisindolylmaleimide I and SB 203580.Wnt5a-stimulated
villin protein was prevented with the addition of D4476. Screening for
immunoreactive β-actin in cell lysates was conducted to show equal
loading. TheseWestern blots are representative of three individually
performed experiments.
RECOMBINANT Wnt5a, BUT NEITHER Wnt3a NOR EGF, STIMULATED
VILLIN PROTEIN PRODUCTION IN ADENOCARCINOMA-DERIVED CELLS
To determine whether other forms of Wnt5a or other Wnt fam-
ily members, besides Wnt5a, could stimulate villin protein pro-
duction in HT29 cells, we challenged WT Ror2-overexpressing
cells with recombinant mouse Wnt5a (rWnt5a) and recombi-
nant mouse Wnt3a (rWnt3a), and assessed for villin protein
production. In mock-transfected cells treated with Wnt5a CM,
levels of villin protein were low, as observed in previous exper-
iments. Upon addition of either Wnt5a conditioned media or
rWnt5a (200 ng/mL) for 24 h in Ror2-overexpressing cells, lev-
els of villin protein were increased. Following similar addition of
rWnt3a (200 ng/mL) to WT Ror2-transfected cells, villin protein
production was not increased (Figure 6A).
To determine whether other ERK1/2 agonists could induce
increased villin production, we stimulated cells with EGF. EGF
is a well-characterized activator of the ERK1/2 cascade. Western
blot analysis screening for pERK1/2 conﬁrmed that EGF (100 nM)
stimulated transient and robust increases in dual-ERK1/2 (both
p44/p42) phosphorylation between 2 and 30min of incubation
(Figure 6B). Upon immunoblotting for villin protein, we found,
as with previous experiments, that the levels of villin protein
expression in unchallenged or mock-transfected cells were not
increased. In contrast, in WT Ror2-transfected cells challenged
with Wnt5a CM for 24 h, villin protein expression was noticeably
increased, within the same experiment. However, in WT Ror2-
transfected cells treated with EGF for a similar 24 h time period,
immunoreactive villin was low (Figure 6C).
From these experiments,we conclude that bothWnt5a CMand
recombinant Wnt5a treatment stimulated villin protein produc-
tion. However, treatment with either another Wnt family mem-
ber, Wnt3a, or a separate ERK1/2 agonist, EGF, did not induce
enhanced villin production.
Wnt5a-INDUCED ERK1/2-DEPENDENT VILLIN PROTEIN PRODUCTION IN
Ror2-TRANSFECTED FETALLY DERIVED NON-TRANSFORMED HUMAN
INTESTINAL EPITHELIAL CELLS
Fromourprevious experiments,weobserved that adenocarcinoma-
derived HT29 cells expressed increasing basal levels of villin pro-
tein with passage. Thus, we elected to repeat similar experiments
in fetally derived non-transformed human intestinal epithelial
(HIECs), which normally express very little or no villin protein.
To assess whether villin protein production is stimulated by
Wnt5a–Ror2 in fetal non-transformed HIECs, we completed
immunoblotting for villin in cells overexpressing the Ror2 recep-
tor and had been challenged with Wnt5a CM for 24 h. As seen
in previous experiments, in unchallenged and mock-transfected
cells, levels of villin protein were low. In Ror2-overexpressing cells,
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FIGURE 4 | Levels ofWnt5a-induced ERK1/2 phosphorylation were
diminished or conserved in HT29 cells, depending on type of Ror2
construct expressed. (A–D) Left panels: ERK1/2 phosphorylation was
attenuated inWnt5a-challenged cells transfected with: ΔCRD Ror2 (where
the cysteine-rich domain of Ror2 was been deleted); ΔK Ror2
(characterized by a deletion of the kringle domain), RS Ror2 (which
contained a truncation of regions distal to and including a major portion of
the tyrosine kinase domain); or 5YF Ror2 (where ﬁve tyrosine residues of
the Ser/Thr-1 region had been substituted with phenylalanines). (E) Left
panel: however,Wnt5a-treated HT29 cells transfected with BDB Ror2
(where the entire proline and serine rich regions was deleted), display a
similar level and pattern of ERK1/2 phosphorylation compared toWT
control cells. Screening for immunoreactive total ERK1/2 was included as
an internal loading control. The blots discussed are representative of three
separate experiments with similar results. (A–E) Right panels:
densitometry conﬁrmed that maximal ERK1/2 phosphorylation in
Wnt5a-challengedWT Ror2 control cells consistently occurred at 10min.
Additionally, maximal ERK1/2 phosphorylation was signiﬁcantly more
intense compared to baseline and compared to ERK1/2 phosphorylation in
similarly treated cells expressing a truncated or mutated Ror2. (E) Right
panel: the pattern and degree of ERK1/2 phosphorylation was conserved
in BDB Ror2-transfected cells challenged withWnt5a. Results are
expressed as means±SD of three independently performed experiments.
*P <0.05 compared to 10min ofWnt5a CM incubation in truncated or
mutant Ror2-transfected cells. †P <0.05 compared to 0min ofWnt5a
incubation inWT Ror2-transfected cells.
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FIGURE 5 |Wnt5a-challenge attenuated villin protein expression in
cells transfected with ΔCRD Ror2 and 5YF Ror2, but villin expression
was increased in BDB Ror2-expressing cells. (A)Wnt5a challenge
induced a noticeable upregulation in villin protein expression in
Ror2-overexpressing HT29 cells, as previously observed. In similarly
challenged cells transfected with a ΔCRD Ror2 construct, where the
cysteine-rich domain of the receptor has been deleted, or with 5YF Ror2, a
plasmid construct where ﬁve tyrosines of the Ser/Thr-1 region had been
substituted with phenylalanines, villin protein expression was not
increased. These low levels of villin expression resembled those found in
mock-transfected and/or untreated control cells. β-actin immunoblotting
was completed to show equal loading. Blots were representative of three
separately performed experiments. (B) In HT29 cells transfected with BDB
Ror2, which is characterized by a deletion of the proline and
serine/threonine-rich domains of the receptor, levels of villin protein
expression were increased uponWnt5a CM challenge. This increased villin
expression was comparable to that observed in similarly challengedWT
Ror2-transfected cells. These results represent three individually performed
experiments with similar results. Western blotting for β-actin was included
as a loading control.
without Wnt5a stimulation, there was a slight increase in villin
expression. With Wnt5a addition to WT Ror2-overexpressing
cells, there was a noticeable increase in villin protein production
(Figure 7).
To assess if this Wnt5a-induction of villin was ERK1/2-
mediated, we challenged WT Ror2-overexpressing fetal-derived
non-transformed HIECs with Wnt5a CM for 0, 2, 5, 10, and
60min andmeasured levels of ERK1/2 phosphorylation.We found
that there was a transient and robust increase in dual-ERK1/2
phosphorylation over the course of an hour. Maximal ERK1/2
phosphorylation occurred between 5 and 10min (Figure 7B). This
pattern of ERK1/2 phosphorylation resembled that of similarly
challenged WT Ror2-overexpressing HT29 cells (Figure 2C).
To determine which intracellular signaling cascades medi-
ated this Wnt5a-stimulated villin production, we challenged WT
Ror2-expressing cells with Wnt5a CM in presence of MEK-1
inhibitor (10μM; PD 098059), Bisindolylmaleimide I (1μM; an
inhibitor of PKC-α, -β, -γ, -δ, -ε), SB 203580 (10μM; a speciﬁc
inhibitor of all p38 isotypes), and D4476 (100μM; an inhibitor
of CKI isotypes), and assessed for levels of villin protein. In the
presence of either PD 098059 or D4476, levels of villin pro-
tein were not increased upon Wnt5a addition (Figures 7C,D).
FIGURE 6 | Incubation with recombinantWnt5a, but not recombinant
Wnt3a nor EGF enhanced villin protein expression. (A) InWT
Ror2-transfected HT29 cells, villin protein was slightly increased compared
toWnt5a CM-treated mock-transfected cells. There was a noticeable
increase in similarly treatedWT Ror2-overexpressing cells. Incubation with
rWnt5a (200 ng/mL) for 24 h enhanced villin expression to a similar degree.
Treatment with rWnt3a (200 ng/mL) for 24 h did not induce any
immunoreactive villin expression. (B) Challenge with EGF (100 nM) for 0, 2,
5, 10, 30, 60min induced transient and robust increases in ERK1/2
phosphorylation in HT29 cells. In contrast, weak pERK1/2 immunoreactivity
was detected in cells which had been challenged with low serum media,
which did not contain EGF, over similar time points. (C) As previously
observed, in HT29 cells which were mock-transfected or left untreated, low
levels of villin protein expression were detected. InWT
Ror2-overexpressing cells challenged withWnt5a conditioned media for
24 h, villin protein expression was increased. InWT Ror2-overexpressing
cells, challenged with EGF for a similar 24 h time period, low levels of villin
expression were detectable, comparable to that found in mock-transfected
or untreated control cells. β-actin immunoblotting was included as a loading
control. These results are representative of three separately performed
experiments.
However, incubation with Bisindolylmaleimide I or SB 203580
did not prevent the Wnt5a-stimulated increases in villin protein
(Figure 7D).
From these experiments, we conclude that villin protein
expression is enhanced upon WT Ror2 overexpression but villin
expression was further increased with Wnt5a treatment. This
Wnt5a-stimulated villin protein was likelymediated by an ERK1/2
MAPK cascade and/or by casein kinase I.
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FIGURE 7 |Wnt5a challenge stimulated villin expression, via an
ERK1/2-dependent mechanism inWT Ror2-overexpressing human
intestinal epithelial cells (HIECs). (A) Villin protein was barely detectable in
mock-transfected and/or unchallenged HIECs. UponWnt5a treatment, levels
of villin transcript expression were slightly increased. Overexpression ofWT
Ror2 in these cells induced faint villin expression. TreatingWT Ror2-cells
withWnt5a CM for 24 h noticeably enhanced villin protein expression. (B)
Wnt5a addition in Ror2-overexpressing cells transiently and robustly
increased dual-ERK1/2 phosphorylation over the course of an hour. (C)The
Wnt5a-enhanced villin protein expression was prevented in similarly treated
cells, in the presence of PD 098059 (10μM). (D) However, increased villin
protein levels were maintained inWnt5a-challengedWT Ror2-cells, despite
the presence of either Bisindolylmaleimide I (1μM) or SB 203580 (10μM).
Yet, in the presence of D4476 (100μM),Wnt5a-induced villin protein
expression was prevented For all experiments described,Western blotting
for immunoreactive β-actin was performed to demonstrate equal loading.
These experiments reﬂect results from similar experiments performed
separately.
THE Ser/Thr-1 DOMAIN OF THE Ror2 RECEPTOR DIFFERENTIALLY
MEDIATED VILLIN PROTEIN PRODUCTION IN HIECS
To determine which regions of the Ror2 receptor were necessary
to mediateWnt5a-induced villin protein production in fetal non-
transformed HIECs, we completed Western blotting for villin in
lysates collected from Wnt5a-treated cells where ﬁve critical tyro-
sine residues in the serine/threonine-1 region of Ror2 had been
substituted with phenylalanine (5YF Ror2) or where the proline
and serine/threonine-rich regions of the receptor had been deleted
(BDB Ror2; Figure 8A). As previously observed, in unchallenged
WT Ror2 (control) cells, we found low, but detectable levels of
villin protein expression. Upon Wnt5a treatment in WT Ror2-
overexpressing cells, levels of villin protein were increased. In
contrast, in both untreated or Wnt5a CM-challenged 5YF Ror2-
transfected cells, immunoreactive villin protein was undetectable.
In untreated BDB Ror2-expressing cells, we observed low lev-
els of immunoreactive villin protein, comparable to levels seen
in untreated WT Ror2-transfected HIECs. In Wnt5a-challenged
BDB Ror2-overexpressing cells, the amount of villin protein was
increased, comparable to that seen in similarly challenged WT
Ror2-overexpressing cells. The results from these experiments
were consistent with data collected from previous experiments
in HT29 cells (Figures 5A,B). Though both 5YF Ror2 and
BDB Ror2 eliminated tyrosine phosphorylation in the Ser/Thr-
1 domain, upon Wnt5a treatment, these mutant/truncated Ror2
constructs signaled in a different manner. The tyrosine phos-
phorylation in Ser/Thr-1 domain was necessary in full length
Ror2 but not in a truncated version Ror2 where the regions
including, and distal to, the Ser/Thr-1 region were eliminated.
Thus, in both transformed (HT29 cells) and fetally derived non-
transformed (HIECs) human intestinal epithelial,Wnt5a signaled
differently in 5YF mutations compared with the BDB deletions
of Ror2.
Wnt3a DID NOT ENHANCE VILLIN PROTEIN PRODUCTION IN
NON-TRANSFORMED HUMAN INTESTINAL EPITHELIAL CELLS
To determine whether another Wnt family member (Wnt3a) or
another ERK1/2 agonist (EGF) would stimulate villin protein pro-
duction in fetally derived non-transformed HIECs, we treated
cells with either rWnt3a or EGF and probed for immunoreactive
villin. Consistent with previous experiments, in mock-transfected
HIECs villin protein production was faint. Upon WT Ror2-
transfection, villin protein production was slightly increased. In
Ror2-overexpressing cells challenged with Wnt5a CM for 24 h,
villin protein expression was substantially increased. However,
when WT Ror2-transfected cells were challenged, similarly for
24 h, with rWnt3a protein (200 ng/mL), levels of villin protein
production were unchanged, comparable to levels observed in
untransfected and untreated control cells (Figure 8B).
DISCUSSION
The major ﬁndings from this study are summarized in the
schematic (Figure 9). We found that Wnt5a/Ror2 signaling
caused ERK1/2 activation and subsequent villin protein expres-
sion in HT29 adenocarcinoma cells and a fetally derived non-
transformed human intestinal epithelial cell line. Evidence that
Wnt5a-stimulated Ror2 to induce ERK1/2 activation was demon-
strated by different experimental approaches.Western blotting for
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FIGURE 8 |Wnt5a treatment did not stimulate villin protein expression
in 5YF Ror2-expressing HIECs but did induce villin protein expression
in BDB Ror2-expressing HIECs. (A) In untreatedWT Ror2-expressing
cells, villin protein expression was not detectable; uponWnt5a challenge
for 24 h, villin expression was substantially increased. Levels of villin protein
were low in untreated andWnt5a-treated 5YF Ror2-expressing cells. Similar
Wnt5a treatment upregulated the amount of immunoreactive villin in cells
transfected with BDB Ror2. β-actin immunoreactivity was assessed to
conﬁrm equivalent loading. These results are representative of three
separate experiments. (B) Incubation with recombinantWnt3a protein did
not stimulate villin protein expression in Ror2-overexpressing HIECs. Villin
protein expression was not detectable in untreated mock-transfected HIEC,
but was slightly enhanced in untreatedWT Ror2- expressing cells. Villin
protein expression was noticeably increased withWnt5a CM-challenge for
24 h inWT Ror2-overexpressing cells. In similarly transfected cells, rWnt3a
incubation for a 24-h period did not induce increases in villin protein. β-actin
immunoreactivity was assessed to conﬁrm equivalent loading. These
results are representative of three separate experiments.
ERK1/2 showed thatWnt5a conditionedmedia treatment induced
transient and robust increases in ERK1/2 phosphorylation in
Ror2-overexpressing intestinal epithelial cells.Media change alone
failed to stimulate ERK1/2 phosphorylation. Ror2 expressionwas a
necessary component of Wnt5a-induced ERK1/2 activation, since
when Ror2 expression was reduced by RNAi, this phosphorylation
was attenuated. Results of structure–function studies suggested
the requirement of the cysteine-rich, kringle, and tyrosine kinase
domains of Ror2 for Wnt5a-mediated activation of the ERK1/2
MAPK cascade in these cells. Wnt5a addition did not stimu-
late ERK1/2 activation in cells which expressed a Ror2 receptor
with ﬁve substitution-mutated tyrosines in the Ser/Thr-1 rich
region (5YF Ror2). However, cells which expressed a Ror2 with
the serine/threonine and proline-rich regions deleted (BDBRor2),
Wnt5a caused robust increases in ERK1/2 phosphorylation. We
report that expression levels of these different Ror2 constructs
in the endogenously Ror2-expressing HT29 cells varied. If our
Wnt5a-stimulated ERK1/2 responses were dictated by differences
in the expression levels it is difﬁcult to understandhow the robustly
overexpressed RS-Ror2 generated a different response (inhibition
of ERK1/2), comparedwith the BDBRor2 (no inhibition). Indeed,
even when expressed at a lower level compared with the WT
Ror2, the ΔK and 5YF constructs inhibited theWnt5a-stimulated
ERK1/2. Because both the 5YF and BDB Ror2 constructs elimi-
nated tyrosine phosphorylation function in the Ser/Thr-1 domain,
FIGURE 9 | Model ofWnt-induced villin protein expression in
adenocarcinoma-derived HT29 cells and fetally derived, untransformed
human intestinal epithelial cells.Wnt5a interaction with Ror2 is mediated
by the cysteine-rich domain. Phosphorylation of the tyrosines within in the
Ser/Thr-1 region, possibly by Src, induces ERK1/2 phosphorylation.
Stimulated ERK1/2 upregulates villin transcript expression; this
subsequently increases villin protein. ThisWnt5a-induced villin expression is
also mediated by CK1. As well, CDX2, acting downstream of, or in parallel
with, the activated ERK1/2 MAPK cascade could be mediating
Wnt5a-induced increases in villin protein.
we conclude thatWnt5a interacted with these constructs to signal
differently pERK1/2 and increases in villin protein.
Villin protein was increased afterWnt5a-induced ERK1/2 acti-
vation in the two model cell lines. Villin protein expression was
blocked in the presence of a speciﬁc inhibitor of MEK-1, an
upstreammediator of the ERK1/2MAPK signaling cascade, and in
the presence of a casein kinase 1 (CK1) inhibitor,Wnt5a-enhanced
villin expression was prevented. However, enhanced villin protein
expression was not blocked in the presence of a general PKC or
p38 inhibitor. These results suggested that non-canonical Wnt5a-
activation of ERK1/2was highly speciﬁc, as a canonicalWnt family
member, Wnt3a, and EGF, a separate ERK1/2 agonist, failed to
stimulate villin protein production. Together, these ﬁndings from
a reductionistic system suggested Wnt5a/Ror2 signaling could
regulate villin production in intestinal epithelia.
Wnt5a/Ror2 signaling is mediated through the functional
domains of the Ror2 receptor. For instance, Wnt5a interaction
with Ror2 expressed inHT29,HEK, L,H441, andA549 cells antag-
onized β-catenin TopFlash reporter activity (Mikels and Nusse,
2006; MacLeod et al., 2007; Li et al., 2008). These effects were
mediated by the intracellular domain of the receptor (Mikels and
Nusse, 2006; Abdullah et al., 2008). In contrast, Wnt1 challenge
in human sarcoma cells stimulated the tyrosine kinase domain of
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Ror2 and subsequent β-catenin reporter activity (Billiard et al.,
2005). The current report describes that Wnt5a/Ror2 activation
stimulates an ERK1/2 MAPK cascade. Indeed, we have demon-
strated that the cysteine-rich,kringle, and tyrosine kinase domains,
and likely tyrosine phosphorylation within the serine/threonine-1
region, are involved inmediating theMAPK cascade and increases
in villin.
In our experiments, we observed that Wnt5a-stimulated
ERK1/2 phosphorylation in cells expressing BDB Ror2, but not
in cells expressing a 5YF Ror2. Insight into the function of the
C-terminus (Ser/Thr-1 and proline regions) of Ror2 has been gen-
erated in a study showing that the C-terminus was required for
the recruitment of the non-receptor kinase Src (Akbarzadeh et al.,
2008). Pharmacological inhibition of Src suppressed Ror2 activa-
tion (Akbarzadeh et al., 2008). One interpretation of these results
was that the BDB Ror2 was defective in kinase activation via fail-
ure to recruit Src. Our current results showing 5YFRor2 prevented
pERK1/2 stimulation and villin protein increases, while BDB Ror2
had no effect, suggest to us that recruitment of Src and phosphory-
lation of the ﬁve tyrosines in the BDB region were a necessary and
sufﬁcient event for Wnt5a-activation of Ror2 to generate tran-
sient pERK1/2 stimulation leading to villin production. Clearly,
Wnt5a interaction with 5YF Ror2 and BDB Ror2 was different.
Further experiments are required to delineate how Src ismobilized
by Wnt5a stimulation, as well as the role of Src in villin protein
regulation. While it is known from in vitro experiments that Src
tyrosine phosphorylated villin, leading to increased intestinal cell
migration as well as a villin-mediated anti-apoptosis, these effects
were observed in models of villin overexpression (Mathew et al.,
2008).Our current experiments have focused onhowWnt5a inter-
action with Ror2 led to increases in villin. To date, we are unaware
of studies which have compared the functions of 5YF Ror2 and
BDB Ror2 followingWnt5a stimulation. While we know that 5YF
Ror2 failed to phosphorylate G-protein receptor kinase-2 (GRK2)
on tyrosine residues by ectopic expression of CK1ε, those studies
did not test whether or not BDB Ror2 stimulated GRK2 (Kani
et al., 2004). In future studies, it will be important to understand
how putative Src activation of the 5YF sites in the Ser/Thr-1 region
alter function compared with the absence of the Ser/Thr-1 region
altogether. Are other tyrosine sites in the intracellular domain Src
phosphorylated in the regions deleted in BDB Ror2? We report
that in these endogenously Ror2-expressing cells, the BDB and
5YF levels were not comparable. Indeed, there was more BDB and
less 5YF comparedwith thewild-typeRor2. If increased expression
was a determinant of theWnt5a-stimulated pERKs, then presum-
ably both constructs would have behaved the same. They did not.
Even when expressed at a lower level the 5YF construct blocked
Wnt5a stimulation of pERK,while the greater level of BDB had no
effect. Therefore, our current results strongly suggest that tyrosine
phosphorylation, likely mediated by Src kinases, at sites within
the proline–serine/threonine-rich regions of Ror2 are essential for
ERK1/2 MAPK stimulation and villin protein production.
Earlier work has implicated ERK1/2 phosphorylation in stim-
ulating intestinal epithelial differentiation (Houde et al., 2001).
Indeed, others have shown in H. pylori – gastric cancer cells, that
villin promoter activity is stimulated by Elk-1, a transcription
factor which is downstream of the ERK MAPK cascade (Rieder
et al., 2005). These studies were consistent with our ﬁndings
that Wnt5a/Ror2 signaling will stimulate ERK1/2 phosphoryla-
tion. This event likely mediates villin protein production. We
have shown that pharmacological inhibition of MEK-1 prevented
Wnt5a-mediated increases in villin protein in two distinct epithe-
lial model cell types. However, pharmacological inhibition of PKC
isoforms -α, -β, -γ, -δ, -ε, and p38 MAPK isoforms had no effect
on Wnt5a-induced villin protein expression in HT29 adenocarci-
noma cells or in non-transformed fetal-derived human intestinal
epithelia. Previous studies using Ror2 in heterologous cell lines
have shown that Wnt5a stimulates JNK (Yamanaka et al., 2002)
and GSK-3β (Yamamoto et al., 2008), while the receptors which
mediate p38, PKC, or CK1/2 following Wnt5a stimulation have
not yet been identiﬁed.
Our current work is consistent with previous ﬁndings that
CK1 mediates Wnt signaling in the intestine, as Wnt5a-induction
of villin protein was prevented by pharmacological inhibition
of CK1 (Bryja et al., 2007). Little is understood about the role
of CK1 in the intestine. It is known that CK1ε abundance and
activity increased in transmissible murine colonic hyperplasia,
suggesting CK1ε modulated hyperproliferation in mouse epithe-
lia (Umar et al., 2007). Such ﬁndings are consistent with CK1 as
a positive regulator of Wnt/β-catenin signaling. However, other
studies have demonstrated that Wnt5a-mediated dopaminergic
neuronal differentiation was blocked in the presence of D4476.
However, the speciﬁc receptor mediating this effect was not inves-
tigated (Bryja et al., 2007). Our work is consistent with previous
ﬁndings that CK1 mediates Wnt signaling in the intestine, as
Wnt5a-induction of villin protein was prevented by pharmacolog-
ical inhibitionof CK1. In future experiments itwill be important to
understand if Wnt5a-mediated CK1 phosphorylation precedes or
follows ERK1/2 activation, or does this signaling occur in parallel?
The villin promoter has CDX2 responsive sites (Yamamichi
et al., 2009). Previously we reported Wnt5a/Ror2 signaling in
HT29 and Caco-2 adenocarcinoma cells, profoundly increased
both CDX2 transcript and protein leading to activation of a
sucrase-isomaltase promoter. Addition of rhWnt5a to these cells
caused a 15-fold increase in CDX2 protein within 1h which
declined to threefold over basal level by 2 h (Pacheco andMacLeod,
2008). The determinants of CDX2 protein half-life are largely
unknown, but phosphorylation by p38 MAP kinase has been
reported to increase CDX2 half-life (Houde et al., 2001). Because
the increase in CDX2 transcript and protein occurred at longer
times compared with the activation of pERK1/2 described in the
current studies, itmay be that theWnt5a stimulationof pERK1/2 is
an important determinant of the upregulation of CDX2 transcript
or the substantial increases in CDX2 protein. The current studies
have not investigated whether Wnt5a-induction of CDX2 pro-
tein is a necessary determinant of the subsequent stimulation of
villin. Further experiments are needed to reduce CDX2 increases
and address whether the Ror2-stimulation of pERK1/2 is inﬂu-
enced and if villin transcript and protein changes have occurred.
Indeed,because the current studies show that EGF caused the same
transient stimulation of pERK1/2 in Ror2-overexpressing cells but
did not cause an increase in villin protein, it will be important to
know if EGF increases CDX2 in these cells. Alternatively it could be
that while both CDX2 and Elk-1 can activate the villin promoter,
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either factor alone is sufﬁcient for villin production. While we
have shown that Wnt5a stimulation of Ror2 will increase CDX2,
we do not know if this precedes or is in parallel with pERK1/2
activation. Our current evidence strongly supports, however, sig-
naling of Wnt5a/Ror2 on intestinal epithelia stimulating pERK1/2
to increase villin transcript and protein.
We proposed thatWnt5a–Ror2 induction of ERK1/2 and villin
requires CK1. We have observed in both non-transformed, fetally
derived HIEC, and HT29 cells that Ror2 overexpression stim-
ulates villin expression. This could likely be mediated by Ror2
homodimerization triggering kinase activity independently from
Wnt5a. Several studies have shown that though Wnt5a addi-
tion induced activation of wild-type Ror2 kinase (Billiard et al.,
2005; Akbarzadeh et al., 2008). Additionally, in the absence of
Wnt5a, a constitutively dimerized form of Ror2 exhibited tyro-
sine kinase activity (Akbarzadeh et al., 2008; Liu et al., 2008). Our
lab has previously reported that Ror2 is expressed in intestinal
epithelia throughout the crypt–villus axis (Pacheco andMacLeod,
2008). Interestingly, Ror2 and villin share similar expression pro-
ﬁles. Villin protein is also widely expressed in intestinal epithelia,
though its expression is progressively increased as cells migrate
toward the tip of the villi (Dudouet et al., 1987). Additionally,Ror2
and CDX2 also share similar expression proﬁles: both are localized
to intestinal epithelia throughout the crypt–villus axis (Mallo et al.,
1997). Use of transgenic ﬂoxed Ror2 mice are required to answer
this question in vivo. Whether Ror2, alone or working as a co-
receptor, induces villin expression in the intestine independent of
Wnt5a is not known.
We conclude that Wnt5a/Ror2 signals to stimulate pERK1/2
and subsequent villin protein expression in adenocarcinoma-
derived intestinal HT29 cells and non-transformed, fetally derived
HIEC.We have shown thatWnt5a signals differently in 5YF Ror2-
expressing cells compared to BDB Ror2-expressing cells, though
both Ror2 constructs eliminate tyrosine phosphorylation in the
Ser/Thr-1 regions. Additionally, we have demonstrated that CK1
is required for Wnt5a-induced villin protein expression. Together
the current study demonstrates Wnt5a-mediated non-canonical
signaling requiring Ror2 will regulate villin in intestinal epithelial
cells.
ACKNOWLEDGMENTS
Weacknowledge funding from theCrohn’s andColitis Foundation
of Canada (CCFC), CIHR, and NSERC-Dairy Farmers of Canada.
All Ror2 plasmids were a gift from Y. Minami (Kobe, Japan). R.
John Macleod is supported through the Canada Research Chairs
program.
REFERENCES
Abdullah, H. I., Pedraza, P. L., McGiff,
J. C., and Ferreri, N. R. (2008). CaR
activation increases TNFproduction
by mTAL cells via a Gi-dependent
mechanism. Am. J. Physiol. Renal
Physiol. 294, F345–F354.
Akbarzadeh, S., Wheldon, L. M., Sweet,
S. M., Talma, S., Mardakheh, F. K.,
and Heath, J. K. (2008). The deleted
in brachydactyly B domain of ROR2
is required for receptor activa-
tion by recruitment of Src. PLoS
ONE 3, e1873. doi: 10.1371/jour-
nal.pone.0001873
Alessi, D. R., Cuenda, A., Ohen, P.,
Udley, D. T., and Altiel, A. R. (1995).
PD 098059 is a speciﬁc inhibitor of
the activation of mitogen-activated
protein kinase kinase in vitro
and in vivo. J. Biol. Chem. 270,
27489–27494.
Aliaga, J. C., Deschenes, C., Beaulieu,
J. F., Calvo, E. L., and Rivard, N.
(1999). Requirement of the MAP
kinase cascade for cell cycle progres-
sion and differentiation of human
intestinal cells. Am. J. Physiol. 277,
G631–G641.
Billiard, J., Way, D. S., Seestaller-Wehr,
L. M., Moran, R. A., Mangine, A.,
and Bodine, P.V. (2005). The orphan
receptor tyrosine kinase Ror2 mod-
ulates canonical Wnt signaling in
osteoblastic cells. Mol. Endocrinol.
19, 90–101.
Bryja, V., Schulte, G., Rawal, N.,
Grahn, A., and Arenas, E. (2007).
Wnt-5a induces Dishevelled
phosphorylation and dopaminergic
differentiation via a CK1-dependent
mechanism. J. Cell Sci. 120(Pt 4),
586–595.
Clerk, A., Michael, A., and Sugden, P.
H. (1998). Stimulation of multi-
plemitogen-activated protein kinase
sub-families by oxidative stress and
phosphorylation of the small heat
shock protein, HSP25/27, in neona-
tal ventricular myocytes. Biochem. J.
333(Pt 3), 581–589.
Coluccio, L. M., and Bretscher, A.
(1989). Reassociation of microvillar
core proteins: making a microvil-
lar core in vitro. J. Cell Biol. 108,
495–502.
Costa de Beauregard, M. A., Pringault,
E., Robine, S., and Louvard, D.
(1995). Suppression of villin expres-
sion by antisenseRNA impairs brush
border assembly in polarized epithe-
lial intestinal cells. EMBO J. 14,
409–421.
Dudouet, B., Robine, S., Huet, C.,
Sahuquillo-Merino, C., Blair, L.,
Coudrier, E., and Louvard, D.
(1987). Changes in villin syn-
thesis and subcellular distribution
during intestinal differentiation of
HT29-18 clones. J. Cell Biol. 105,
359–369.
George,S. P.,Wang,Y.,Mathew,S., Srini-
vasan, K., and Khurana, S. (2007).
Dimerization and actin-bundling
properties of villin and its role
in the assembly of epithelial cell
brush borders. J. Biol. Chem. 282,
26528–26541.
Houde, M., Laprise, P., Jean, D.,
Blais, M., Asselin, C., and Rivard,
N. (2001). Intestinal epithelial cell
differentiation involves activation
of p38 mitogen-activated protein
kinase that regulates the homeobox
transcription factor CDX2. J. Biol.
Chem. 276, 21885–21894.
Kani, S., Oishi, I., Yamamoto, H., Yoda,
A., Suzuki, H., Nomachi, A., Iozumi,
K., Nishita, M., Kikuchi, A., Takumi,
T., and Minami, Y. (2004). The
receptor tyrosine kinase Ror2 asso-
ciates with and is activated by casein
kinase Iepsilon. J. Biol. Chem. 279,
50102–50109.
Khurana, S., and George, S. P. (2008).
Regulation of cell structure and
function by actin-binding proteins:
villin’s perspective. FEBS Lett. 582,
2128–2139.
Li, C., Chen, H., Hu, L., Xing, Y., Sasaki,
T., Villosis, M. F., Li, J., Nishita,
M., Minami, Y., and Minoo, P.
(2008). Ror2 modulates the canon-
ical Wnt signaling in lung epithe-
lial cells through cooperation with
Fzd2. BMC Mol. Biol. 9, 11. doi:
10.1186/1471-2199-9-11
Liu, Y., Rubin, B., Bodine, P. V., and
Billiard, J. (2008). Wnt5a induces
homodimerization and activation of
Ror2 receptor tyrosine kinase. J. Cell.
Biochem. 105, 497–502.
MacLeod, R. J., Hayes, M., and
Pacheco, I. (2007). Wnt5a secre-
tion stimulated by the extra-
cellular calcium-sensing receptor
inhibits defective Wnt signaling in
colon cancer cells. Am. J. Phys-
iol. Gastrointest. Liver Physiol. 293,
G403–G411.
Mallo, G. V., Rechreche, H., Frige-
rio, J. M., Rocha, D., Zweibaum,
A., Lacasa, M., Jordan, B. R.,
Dusetti, N. J., Dagorn, J. C., and
Iovanna, J. L. (1997). Molecular
cloning, sequencing and expression
of the mRNA encoding human
Cdx1 and Cdx2 homeobox. Down-
regulation of Cdx1 and Cdx2
mRNA expression during colorec-
tal carcinogenesis. Int. J. Cancer 74,
35–44.
Mathew, S., George, S. P., Wang,
Y., Siddiqui, M. R., Srinivasan,
K., Tan, L., and Khurana, S.
(2008). Potential molecular mecha-
nism for c-Src kinase-mediated
regulation of intestinal cell
migration. J. Biol. Chem. 283,
22709–22722.
Maunoury, R., Robine, S., Pringault,
E., Leonard, N., Gaillard, J. A.,
and Louvard, D. (1992). Develop-
mental regulation of villin gene
expression in the epithelial cell lin-
eages of mouse digestive and uro-
genital tracts. Development 115,
717–728.
Mikels, A. J., and Nusse, R. (2006).
Puriﬁed Wnt5a protein activates or
inhibits beta-catenin-TCF signaling
depending on receptor context.PLoS
Biol. 4, e115. doi: 10.1371/jour-
nal.pbio.0040115
Pacheco, I. I., andMacLeod,R. J. (2008).
Extracellular calcium-sensing recep-
tor (CaSR) stimulates secretion of
Wnt5a from colonic myoﬁbroblasts
to stimulate CDX2 and sucrase iso-
maltase using Ror2 on intestinal
Frontiers in Physiology | Renal and Epithelial Physiology September 2011 | Volume 2 | Article 58 | 12
Cheung et al. Wnt5a/Ror2 regulation of villin
epithelia.Am. J. Physiol. Gastrointest.
Liver Physiol. 295, G748–G759.
Pinson, K. I., Dunbar, L., Samuelson,
L., and Gumucio, D. L. (1998). Tar-
geted disruption of the mouse villin
gene does not impair the morpho-
genesis of microvilli. Dev. Dyn. 211,
109–121.
Pinto, M., Robine-Leon, S., Appay,
M. D., Triadou, N., Dussaulx, E.,
Lacroix, B., Simon-Assmann, P.,
Haffen, K., Fogh, J., and Zweibaum,
A. (1983). Enterocyte-like differenti-
ation and polarization of the human
colon carcinoma cell line Caco-2 in
culture. Biol. Cell 47, 323–330.
Rena, G., Bain, J., Elliott, M., and
Cohen, P. (2004). D4476, a cell-
permanent inhibitor of CK1,
suppresses the site-speciﬁc
phosphorylation and nuclear
exclusion of FOXO1a. EMBO Rep. 5,
60–65.
Rieder, G., Tessier, A. J., Qiao, X. T.,
Madison, B., Gumucio, D. L., Mer-
chant, J. L. (2005). Helicobacter-
induced intestinal metaplasia in
the stomach correlates with Elk-1
and serum response factor induc-
tion of villin. J. Biol. Chem. 280,
4906–4912.
Toullec,D.,Pianetti,P.,Coste,H.,Bellev-
ergue, P., Grand-Perret, T., Ajakane,
M., Baudet, V., Boissin, P., Boursier,
E., and Loriolle, F. (1991). The bisin-
dolylmaleimide GF 109203X is a
potent and selective inhibitor of pro-
tein kinase C. J. Biol. Chem. 266,
15771–15781.
Tu,Y., and Perdue,M. H. (2006). CD23-
mediated transport of IgE/immune
complexes across human intestinal
epithelium: role of p38 MAPK. Am.
J. Physiol. Gastrointest. Liver Physiol.
291, G532–G538.
Umar, S., Wang, Y., Morris, A. P., and
Sellin, J. H. (2007). Dual alter-
ations in casein kinase I-epsilon
and GSK-3beta modulate beta-
catenin stability in hyperproliferat-
ing colonic epithelia. Am. J. Phys-
iol. Gastrointest. Liver Physiol. 292,
G599–G607.
Vachon, P. H., and Beaulieu, J.
F. (1992). Transient mosaic pat-
terns of morphological and func-
tional differentiation in the Caco-
2 cell line. Gastroenterology 103,
414–423.
Vayro, S., and Silverman, M. (1999).
PKC regulates turnover rate of rabbit
intestinal Na+-glucose transporter
expressed in COS-7 cells. Am. J.
Physiol. 276(Pt 1), C1053–C1060.
Yamamichi, N., Inada, K., Furukawa,
C., Sakurai, K., Tando, T., Ishizaka,
A., Haraguchi, T., Mizutani, T.,
Fujishiro, M., Shimomura, R., Oka,
M., Ichinose, M., Tsutsumi, Y.,
Omata, M., and Iba, H. (2009).
Cdx2 and the Brm-type SWI/SNF
complex cooperatively regulate villin
expression in gastrointestinal cells.
Exp. Cell Res. 315, 1779–1789.
Yamamoto, S., Nishimura, O., Misaki,
K., Nishita, M., Minami, Y., Yone-
mura, S., Tarui, H., and Sasaki,
H. (2008). Cthrc1 selectively acti-
vates the planar cell polarity pathway
of Wnt signaling by stabilizing the
Wnt-receptor complex. Dev. Cell 15,
23–36.
Yamanaka, H., Moriguchi, T.,
Masuyama, N., Kusakabe, M.,
Hanafusa, H., Takada, R., Takada,
S., and Nishida, E. (2002). JNK
functions in the non-canonical
Wnt pathway to regulate convergent
extensionmovements in vertebrates.
EMBO Rep. 3, 69–75.
Zhou, Y., Wang, Q., Evers, B. M.,
and Chung, D. H. (2005). Signal
transduction pathways involved in
oxidative stress-induced intestinal
epithelial cell apoptosis. Pediatr. Res.
58, 1192–1197.
Conﬂict of Interest Statement: The
authors declare that the research was
conducted in the absence of any
commercial or ﬁnancial relationships
that could be construed as a potential
conﬂict of interest.
Received: 17 December 2010; accepted:
19 August 2011; published online: 13
September 2011.
Citation: Cheung R, Kelly J and
Macleod RJ (2011) Regulation of villin
by Wnt5a/Ror2 signaling in human
intestinal cells. Front. Physio. 2:58. doi:
10.3389/fphys.2011.00058
This article was submitted to Frontiers
in Renal and Epithelial Physiology, a
specialty of Frontiers in Physiology.
Copyright © 2011 Cheung , Kelly and
Macleod. This is an open-access arti-
cle subject to a non-exclusive license
between the authors and Frontiers Media
SA, which permits use, distribution and
reproduction in other forums, provided
the original authors and source are cred-
ited and other Frontiers conditions are
complied with.
www.frontiersin.org September 2011 | Volume 2 | Article 58 | 13
